Toledano Miranda Jayne
Chief Executive Officer
Toledano Miranda Jayne has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including ENTX, DERM, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.
On the most recent filing, Toledano Miranda Jayne is listed as Chief Executive Officer at Entera Bio Ltd. Inside the rolling window, Toledano Miranda Jayne reported 1 open-market purchase totaling $20K in ENTX and no open-market sales.
Companies traded
Other insiders at ENTX
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Toledano Miranda Jayne made?
Toledano Miranda Jayne has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including ENTX, DERM since 2025.
Which companies does Toledano Miranda Jayne trade?
Toledano Miranda Jayne has filed SEC Form 4 disclosures for 2 companies, including ENTX, DERM.
When was Toledano Miranda Jayne's most recent SEC Form 4 filing?
Toledano Miranda Jayne's most recent SEC Form 4 filing on Tracefour is dated Jul 16, 2026.
What is Toledano Miranda Jayne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Toledano Miranda Jayne is listed as Chief Executive Officer.
What is Toledano Miranda Jayne's total buy and sell value in the current window?
Inside the rolling retention window, Toledano Miranda Jayne bought $20K and sold $0 based on SEC Form 4 filings.
What was Toledano Miranda Jayne's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 11,000 ENTX shares on 2025-12-29, worth $20K, per SEC Form 4 filings.